EUVIMEDEUVIMED entdecken
Crossref

Involuntary Movements in Cobalamin Deficiency

Hamit Özyürek, Hulya Ince, Haydar Ali Tasdemir, Omer Faruk Aydin

Klinische Pädiatrie · 01.07.2024 · 236 (04) · 223-228

DOI: 10.1055/a-2085-8461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Klinische Pädiatrie, erschienen am 01.07.2024. Verfasst von Hamit Özyürek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Neurology, Ankara City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Vitamin B 12 Deficiency, Vitamin B 12. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Neurologic problems are frequently described in infants with nutritional vitamin B12 (cobalamin) deficiency.Major neurologic consequences of infantile cobalamin deficiency include delays or regression in neurodevelopment and the occurrence of involuntary movements Methods We reviewed the medical records of infants with cobalamin deficiency and divided infants with involuntary movements into two groups as those, who developed involuntary movements during vitamin B12 supplementation (Group I) and those, who developed involuntary movements prior to supplementation therapy (Group II).

Results

We evaluated a total of 32 infants with the diagnosis of cobalamin deficiency. Involuntary movements were observed in 12 out of 32 infants. Group I and Group II consisted of 6 infants each. Of the infants with involuntary movements, five were exclusively breastfed until the time of diagnosis. The majority of infants in Group II had choreoathetoid movements; twitching and myoclonus in the face, tongue, and lips, and tremor in the upper extremities. These involuntary movements disappeared in one to three weeks after clonazepam therapy. In Group I; shaking movements, myoclonus, tremor, and twitching or protrusion were observed in patients’ hands, feet, tongue, and lips on the 3rd-5th day of cobalamin supplementation. These involuntary movements disappeared within 5–12 days of clonazepam therapy.

Conclusion

Recognition of nutritional cobalamin deficiency is important to perform a differential diagnosis of the condition from seizures or other causes of involuntary movements and avoid aggressive therapy and over treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin B 12 DeficiencyVitamin B 12HumansMaleInfantFemaleClonazepamRetrospective StudiesDyskinesia, Drug-InducedChoreaInfant, NewbornDiagnosis, Differential

Substanzen

Vitamin B 12Clonazepam

Autor:innen und Institutionen

  • Pediatric Neurology, Ankara City Hospital, Ankara, Turkey.
  • Pediatric Neurology, VM Medical Park Samsun Hospital, Samsun, Turkey.
  • Pediatric Neurology, Ondokuz Mayis University Faculty of Medicine, Samsun, Turkey.

Zitieren

APA

Özyürek, H., Ince, H., Tasdemir, H. A., & Aydin, O. F. (2024). Involuntary Movements in Cobalamin Deficiency. Klinische Pädiatrie, 236(04), 223-228. https://doi.org/10.1055/a-2085-8461

Vancouver

Özyürek H, Ince H, Tasdemir HA, Aydin OF. Involuntary Movements in Cobalamin Deficiency. Klinische Pädiatrie. 2024;236(04):223-228. doi:10.1055/a-2085-8461

BibTeX
@article{zyrek2024,
  author = {Özyürek, Hamit and Ince, Hulya and Tasdemir, Haydar Ali and Aydin, Omer Faruk},
  title = {Involuntary Movements in Cobalamin Deficiency},
  journal = {Klinische Pädiatrie},
  year = {2024},
  volume = {236},
  number = {04},
  pages = {223--228},
  doi = {10.1055/a-2085-8461}
}
Kostenlos starten →